APO Research
Talk to an analyst

APO RESEARCH · REPORT

NK Cell Therapy

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

Selected research

Market Structure

Global NK Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchNK Cell Therapy Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal NK Cell Therapy Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal NK Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NK Cell Therapy Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal NK Cell Therapy Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.

Report Includes

Read the full market overview

This report provides an overview of the global NK Cell Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NK Cell Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NK Cell Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the NK Cell Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

NK Cell Therapy Segment by Company

Nektar Therapeutics

Innate Pharma SA

Affimed

Chipscreen Biosciences

Fate Therapeutics

Glycostem Therapeutics

Dragonfly Therapeutics

Kiadis Pharma

NantWorks

Nkarta Therapeutics

Fortress Biotech

NK Cell Therapy Segment by Type

NK Cell Therapies

NK Cell Directed Antibodies

NK Cell Therapy Segment by Application

Cancer

Gastrointestinal Diseases

Others

NK Cell Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NK Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of NK Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NK Cell Therapy industry.

Chapter 3: Detailed analysis of NK Cell Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NK Cell Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of NK Cell Therapies Table 3. Key Players of NK Cell Directed Antibodies Table 4. Global NK Cell Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Cancer Table 6. Key Players of Gastrointestinal Diseases Table 7. Key Players of Others Table 8. Global NK Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global NK Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 10. Global NK Cell Therapy Market Share by Region (2021-2026) Table 11. Global NK Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 12. Global NK Cell Therapy Market Share by Region (2027-2032) Table 13. NK Cell Therapy Industry Trends Table 14. NK Cell Therapy Industry Drivers Table 15. NK Cell Therapy Industry Opportunities and Challenges Table 16. NK Cell Therapy Industry Restraints Table 17. Global NK Cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 18. Global NK Cell Therapy Revenue Market Share by Company (2021-2026) Table 19. Global NK Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global NK Cell Therapy Key Company Head Office and Area Served Table 21. Global NK Cell Therapy Company, Product Type & Application Table 22. Global NK Cell Therapy Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global NK Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global NK Cell Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global NK Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 27. Global NK Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 28. Global NK Cell Therapy Revenue Market Share by Type (2021-2026) Table 29. Global NK Cell Therapy Revenue Market Share by Type (2027-2032) Table 30. Global NK Cell Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global NK Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 32. Global NK Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 33. Global NK Cell Therapy Revenue Market Share by Application (2021-2026) Table 34. Global NK Cell Therapy Revenue Market Share by Application (2027-2032) Table 35. Nektar Therapeutics Company Information Table 36. Nektar Therapeutics Business Overview Table 37. Nektar Therapeutics NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Nektar Therapeutics NK Cell Therapy Product Portfolio Table 39. Nektar Therapeutics Recent Development Table 40. Innate Pharma SA Company Information Table 41. Innate Pharma SA Business Overview Table 42. Innate Pharma SA NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Innate Pharma SA NK Cell Therapy Product Portfolio Table 44. Innate Pharma SA Recent Development Table 45. Affimed Company Information Table 46. Affimed Business Overview Table 47. Affimed NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Affimed NK Cell Therapy Product Portfolio Table 49. Affimed Recent Development Table 50. Chipscreen Biosciences Company Information Table 51. Chipscreen Biosciences Business Overview Table 52. Chipscreen Biosciences NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Chipscreen Biosciences NK Cell Therapy Product Portfolio Table 54. Chipscreen Biosciences Recent Development Table 55. Fate Therapeutics Company Information Table 56. Fate Therapeutics Business Overview Table 57. Fate Therapeutics NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Fate Therapeutics NK Cell Therapy Product Portfolio Table 59. Fate Therapeutics Recent Development Table 60. Glycostem Therapeutics Company Information Table 61. Glycostem Therapeutics Business Overview Table 62. Glycostem Therapeutics NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Glycostem Therapeutics NK Cell Therapy Product Portfolio Table 64. Glycostem Therapeutics Recent Development Table 65. Dragonfly Therapeutics Company Information Table 66. Dragonfly Therapeutics Business Overview Table 67. Dragonfly Therapeutics NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Dragonfly Therapeutics NK Cell Therapy Product Portfolio Table 69. Dragonfly Therapeutics Recent Development Table 70. Kiadis Pharma Company Information Table 71. Kiadis Pharma Business Overview Table 72. Kiadis Pharma NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Kiadis Pharma NK Cell Therapy Product Portfolio Table 74. Kiadis Pharma Recent Development Table 75. NantWorks Company Information Table 76. NantWorks Business Overview Table 77. NantWorks NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. NantWorks NK Cell Therapy Product Portfolio Table 79. NantWorks Recent Development Table 80. Nkarta Therapeutics Company Information Table 81. Nkarta Therapeutics Business Overview Table 82. Nkarta Therapeutics NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Nkarta Therapeutics NK Cell Therapy Product Portfolio Table 84. Nkarta Therapeutics Recent Development Table 85. Fortress Biotech Company Information Table 86. Fortress Biotech Business Overview Table 87. Fortress Biotech NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Fortress Biotech NK Cell Therapy Product Portfolio Table 89. Fortress Biotech Recent Development Table 90. North America NK Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 91. North America NK Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 92. North America NK Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 93. North America NK Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 94. North America NK Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America NK Cell Therapy Market Size by Country (2021-2026) Table 96. North America NK Cell Therapy Market Size by Country (2027-2032) Table 97. Europe NK Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe NK Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe NK Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe NK Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe NK Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe NK Cell Therapy Market Size by Country (2021-2026) Table 103. Europe NK Cell Therapy Market Size by Country (2027-2032) Table 104. China NK Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 105. China NK Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 106. China NK Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 107. China NK Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia NK Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia NK Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia NK Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia NK Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia NK Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia NK Cell Therapy Market Size by Country (2021-2026) Table 114. Asia NK Cell Therapy Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa NK Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa NK Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa NK Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa NK Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa NK Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa NK Cell Therapy Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa NK Cell Therapy Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. NK Cell Therapy Product Image Figure 2. Global NK Cell Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global NK Cell Therapy Market Share by Type: 2025 VS 2032 Figure 4. NK Cell Therapies Image Figure 5. NK Cell Directed Antibodies Image Figure 6. Global NK Cell Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global NK Cell Therapy Market Share by Application: 2025 VS 2032 Figure 8. Cancer Image Figure 9. Gastrointestinal Diseases Image Figure 10. Others Image Figure 11. Global NK Cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 13. Global NK Cell Therapy Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global NK Cell Therapy Market Share by Players in 2025 Figure 16. Global Top 5 and 10 NK Cell Therapy Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global NK Cell Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global NK Cell Therapy Revenue Market Share by Type (2021-2032) Figure 20. Global NK Cell Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global NK Cell Therapy Revenue Market Share by Application (2021-2032) Figure 22. North America NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 23. North America NK Cell Therapy Market Share by Type (2021-2032) Figure 24. North America NK Cell Therapy Market Share by Application (2021-2032) Figure 25. North America NK Cell Therapy Market Share by Country (2021-2032) Figure 26. United States NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 27. Canada NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 28. Mexico NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Europe NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 30. Europe NK Cell Therapy Market Share by Type (2021-2032) Figure 31. Europe NK Cell Therapy Market Share by Application (2021-2032) Figure 32. Europe NK Cell Therapy Market Share by Country (2021-2032) Figure 33. Germany NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 34. France NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 35. U.K. NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 36. Italy NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 37. Russia NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 39. China NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 40. China NK Cell Therapy Market Share by Type (2021-2032) Figure 41. China NK Cell Therapy Market Share by Application (2021-2032) Figure 42. Asia NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 43. Asia NK Cell Therapy Market Share by Type (2021-2032) Figure 44. Asia NK Cell Therapy Market Share by Application (2021-2032) Figure 45. Asia NK Cell Therapy Market Share by Country (2021-2032) Figure 46. Japan NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 47. South Korea NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 50. India NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 51. Australia NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa NK Cell Therapy Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa NK Cell Therapy Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa NK Cell Therapy Market Share by Country (2021-2032) Figure 56. Brazil NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 57. South Africa NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 59. Turkey NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 60. Argentina NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 61. UAE NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 62. Egypt NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Chile NK Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • NK Cell Therapies
  • NK Cell Directed Antibodies
Applications
  • Cancer
  • Gastrointestinal Diseases
  • Others
Companies covered
  • Nektar Therapeutics
  • Innate Pharma SA
  • Affimed
  • Chipscreen Biosciences
  • Fate Therapeutics
  • Glycostem Therapeutics
  • Dragonfly Therapeutics
  • Kiadis Pharma
  • NantWorks
  • Nkarta Therapeutics
  • Fortress Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 NK Cell Therapies
  5. 1.2.3 NK Cell Directed Antibodies
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global NK Cell Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Cancer
  9. 1.3.3 Gastrointestinal Diseases
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global NK Cell Therapy Growth Trends by Region
  13. 1.5.1 Global NK Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 NK Cell Therapy Market Size by Region (2021-2026)
  15. 1.5.3 NK Cell Therapy Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global NK Cell Therapy Market Dynamics
  1. 2.1 NK Cell Therapy Industry Trends
  2. 2.2 NK Cell Therapy Industry Drivers
  3. 2.3 NK Cell Therapy Industry Opportunities and Challenges
  4. 2.4 NK Cell Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global NK Cell Therapy Revenue by Company (2021-2026)
  2. 3.2 Global NK Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global NK Cell Therapy Key Company Head office and Area Served
  4. 3.4 Global NK Cell Therapy Company, Product Type & Application
  5. 3.5 Global NK Cell Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global NK Cell Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 NK Cell Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 NK Cell Therapy Tier 1, Tier 2, and Tier 3
4 NK Cell Therapy Market by Type
  1. 4.1 Global NK Cell Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global NK Cell Therapy Market Size by Type (2021-2032)
  3. 4.3 Global NK Cell Therapy Market Size Share by Type (2021-2032)
5 NK Cell Therapy Market by Application
  1. 5.1 Global NK Cell Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global NK Cell Therapy Market Size by Application (2021-2032)
  3. 5.3 Global NK Cell Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Nektar Therapeutics
  2. 6.1.1 Nektar Therapeutics Company Information
  3. 6.1.2 Nektar Therapeutics Business Overview
  4. 6.1.3 Nektar Therapeutics NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Nektar Therapeutics NK Cell Therapy Product Portfolio
  6. 6.1.5 Nektar Therapeutics Recent Developments
  7. 6.2 Innate Pharma SA
  8. 6.2.1 Innate Pharma SA Company Information
  9. 6.2.2 Innate Pharma SA Business Overview
  10. 6.2.3 Innate Pharma SA NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Innate Pharma SA NK Cell Therapy Product Portfolio
  12. 6.2.5 Innate Pharma SA Recent Developments
  13. 6.3 Affimed
  14. 6.3.1 Affimed Company Information
  15. 6.3.2 Affimed Business Overview
  16. 6.3.3 Affimed NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Affimed NK Cell Therapy Product Portfolio
  18. 6.3.5 Affimed Recent Developments
  19. 6.4 Chipscreen Biosciences
  20. 6.4.1 Chipscreen Biosciences Company Information
  21. 6.4.2 Chipscreen Biosciences Business Overview
  22. 6.4.3 Chipscreen Biosciences NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Chipscreen Biosciences NK Cell Therapy Product Portfolio
  24. 6.4.5 Chipscreen Biosciences Recent Developments
  25. 6.5 Fate Therapeutics
  26. 6.5.1 Fate Therapeutics Company Information
  27. 6.5.2 Fate Therapeutics Business Overview
  28. 6.5.3 Fate Therapeutics NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Fate Therapeutics NK Cell Therapy Product Portfolio
  30. 6.5.5 Fate Therapeutics Recent Developments
  31. 6.6 Glycostem Therapeutics
  32. 6.6.1 Glycostem Therapeutics Company Information
  33. 6.6.2 Glycostem Therapeutics Business Overview
  34. 6.6.3 Glycostem Therapeutics NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Glycostem Therapeutics NK Cell Therapy Product Portfolio
  36. 6.6.5 Glycostem Therapeutics Recent Developments
  37. 6.7 Dragonfly Therapeutics
  38. 6.7.1 Dragonfly Therapeutics Company Information
  39. 6.7.2 Dragonfly Therapeutics Business Overview
  40. 6.7.3 Dragonfly Therapeutics NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Dragonfly Therapeutics NK Cell Therapy Product Portfolio
  42. 6.7.5 Dragonfly Therapeutics Recent Developments
  43. 6.8 Kiadis Pharma
  44. 6.8.1 Kiadis Pharma Company Information
  45. 6.8.2 Kiadis Pharma Business Overview
  46. 6.8.3 Kiadis Pharma NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Kiadis Pharma NK Cell Therapy Product Portfolio
  48. 6.8.5 Kiadis Pharma Recent Developments
  49. 6.9 NantWorks
  50. 6.9.1 NantWorks Company Information
  51. 6.9.2 NantWorks Business Overview
  52. 6.9.3 NantWorks NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 NantWorks NK Cell Therapy Product Portfolio
  54. 6.9.5 NantWorks Recent Developments
  55. 6.10 Nkarta Therapeutics
  56. 6.10.1 Nkarta Therapeutics Company Information
  57. 6.10.2 Nkarta Therapeutics Business Overview
  58. 6.10.3 Nkarta Therapeutics NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Nkarta Therapeutics NK Cell Therapy Product Portfolio
  60. 6.10.5 Nkarta Therapeutics Recent Developments
  61. 6.11 Fortress Biotech
  62. 6.11.1 Fortress Biotech Company Information
  63. 6.11.2 Fortress Biotech Business Overview
  64. 6.11.3 Fortress Biotech NK Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Fortress Biotech NK Cell Therapy Product Portfolio
  66. 6.11.5 Fortress Biotech Recent Developments
7 North America
  1. 7.1 North America NK Cell Therapy Market Size (2021-2032)
  2. 7.2 North America NK Cell Therapy Market Size by Type
  3. 7.2.1 North America NK Cell Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America NK Cell Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America NK Cell Therapy Market Share by Type (2021-2032)
  6. 7.3 North America NK Cell Therapy Market Size by Application
  7. 7.3.1 North America NK Cell Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America NK Cell Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America NK Cell Therapy Market Share by Application (2021-2032)
  10. 7.4 North America NK Cell Therapy Market Size by Country
  11. 7.4.1 North America NK Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America NK Cell Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America NK Cell Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America NK Cell Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe NK Cell Therapy Market Size (2021-2032)
  2. 8.2 Europe NK Cell Therapy Market Size by Type
  3. 8.2.1 Europe NK Cell Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe NK Cell Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe NK Cell Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe NK Cell Therapy Market Size by Application
  7. 8.3.1 Europe NK Cell Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe NK Cell Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe NK Cell Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe NK Cell Therapy Market Size by Country
  11. 8.4.1 Europe NK Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe NK Cell Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe NK Cell Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe NK Cell Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China NK Cell Therapy Market Size (2021-2032)
  2. 9.2 China NK Cell Therapy Market Size by Type
  3. 9.2.1 China NK Cell Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China NK Cell Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China NK Cell Therapy Market Share by Type (2021-2032)
  6. 9.3 China NK Cell Therapy Market Size by Application
  7. 9.3.1 China NK Cell Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China NK Cell Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China NK Cell Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia NK Cell Therapy Market Size (2021-2032)
  2. 10.2 Asia NK Cell Therapy Market Size by Type
  3. 10.2.1 Asia NK Cell Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia NK Cell Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia NK Cell Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia NK Cell Therapy Market Size by Application
  7. 10.3.1 Asia NK Cell Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia NK Cell Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia NK Cell Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia NK Cell Therapy Market Size by Country
  11. 10.4.1 Asia NK Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia NK Cell Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia NK Cell Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia NK Cell Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa NK Cell Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa NK Cell Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa NK Cell Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa NK Cell Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa NK Cell Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa NK Cell Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa NK Cell Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa NK Cell Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa NK Cell Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa NK Cell Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa NK Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa NK Cell Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa NK Cell Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa NK Cell Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst